COLL COLLEGIUM PHARMACEUTICAL INC Management Changes 8-K Filing 2025 - Board Changes Collegium Pharmaceutical announced the nomination of Dr. Carlos Paya for election at the 2025 Annual Meeting on March 14, 2025, and the retirement of board members Michael Heffernan and Gwen Melincoff effective at the same meeting. Additionally, David Dieter was appointed as Executive Vice President and General Counsel on March 17, 2025.Get access to all SEC 8-K filings of the COLLEGIUM PHARMACEUTICAL INC